| Literature DB >> 35210393 |
Boon Chin Heng1,2, Yunyang Bai3, Xiaochan Li3, Xuehui Zhang4,5,6, Xuliang Deng7,8,9.
Abstract
The high neurogenic potential of dental and oral-derived stem cells due to their embryonic neural crest origin, coupled with their ready accessibility and easy isolation from clinical waste, make these ideal cell sources for neuroregeneration therapy. Nevertheless, these cells also have high propensity to differentiate into the osteo-odontogenic lineage. One strategy to enhance neurogenesis of these cells may be to recapitulate the natural physiological electrical microenvironment of neural tissues via electroactive or electroconductive tissue engineering scaffolds. Nevertheless, to date, there had been hardly any such studies on these cells. Most relevant scientific information comes from neurogenesis of other mesenchymal stem/stromal cell lineages (particularly bone marrow and adipose tissue) cultured on electroactive and electroconductive scaffolds, which will therefore be the focus of this review. Although there are larger number of similar studies on neural cell lines (i.e. PC12), neural stem/progenitor cells, and pluripotent stem cells, the scientific data from such studies are much less relevant and less translatable to dental and oral-derived stem cells, which are of the mesenchymal lineage. Much extrapolation work is needed to validate that electroactive and electroconductive scaffolds can indeed promote neurogenesis of dental and oral-derived stem cells, which would thus facilitate clinical applications in neuroregeneration therapy.Entities:
Mesh:
Year: 2022 PMID: 35210393 PMCID: PMC8873504 DOI: 10.1038/s41368-022-00164-6
Source DB: PubMed Journal: Int J Oral Sci ISSN: 1674-2818 Impact factor: 24.897
Fig. 1Pro-neurogenic signaling pathways activated by electrical stimuli, via voltage-gated calcium channels or cell surface receptors such as Notch1 and the CNTF receptor. Adapted from Heng et al.[19]. The red pointed arrows denote enhancement, while the red blunted arrows denote inhibition. The black pointed arrows denote chemical transformation or movement of molecules
Direct electrical stimulation on scaffolds for enhancing neurogenic differentiation
| Electroconductive scaffold material | Electric stimuli | Mesenchymal stem/stromal cell source | Species | Neural markers assessed | ref. |
|---|---|---|---|---|---|
| Polyaniline (PANI) | Intermittent D/C for 10 min at 24 h intervals | Not specified | Human | βIII-tubulin, Nestin | [ |
| Electroactuated gold nanoparticles | (1) Steady-state D/C electric field of 100 mV·cm−1 for a duration of 15 min every day, (2) Intermittent square pulses (10, 1, and 0.1 Hz), with a duty cycle of 10% and field strength of 100 mV/cm for 15 min every day | Not specified | Human | βIII-tubulin, Nestin, MAP2, NEFL, GFAP | [ |
| Graphene | Cyclic voltammetry 0.5 V, 0.3 V, and 0.1 V, (1 Hz, 3 Hz, and 5 Hz) | Bone Marrow | Human | MAP2, βIII-tubulin | [ |
| Polycaprolactone (PCL) nanofibre | 4 Hz positive monophasic pulse wave with a 2.5 ms pulse duration and an amplitude of 1.1 V | Adipose | Mouse | Nf-L, Nf-M, Nf-H, SYP), NCAM, GAD, NeuN, βIII-tubulin, and MAP2 | [ |
| Polymethylmethacrylate (PMMA) | D/C ~(8 ± 0.06) mV·mm−1, continuously for 9 days at an exposure of 20 h per day, with a short intermittent resting phase of 4 h for each 24 h | Wharton jelly | Human | SOX2, Nestin, βIII-tubulin | [ |
| Graphene cross-linked collagen cryogel | 1 V D/C for 5 min (0.20 V·mm−1) | Bone marrow | Rat | Nestin, MAP2, βIII-tubulin, NeuN | [ |
| Electrospun carbon nanotube/poly( | 50 mV·mm−1 for 1 h per day, from days 4 to 14 of culture | Adipose tissue | Human | S100b, MBP, GFAP, SOX10, NGFR, NCAM1, FABP7, MP7, MAG | [ |
| Aligned electrospun polypyrrole/ polylactide composite nanofibers | 100 mV·mm−1 for 30 min per day for 5 days | Umbilical cord | Human | Nestin, NF-L | [ |
| Black-phosphorus incorporated gelatin methacryloyl hydrogel | 100 mV·cm−1 for 20 min per day for 1 week | Bone marrow | Rat | Nestin, Tuj1, GFAP, MAP2, | [ |
Carbon nanotube (CNT)-based electroconductive scaffolds for enhancing neurogenic differentiation of mesenchymal stem/stromal cells
| Electroconductive scaffold material | Mesenchymal stem/stromal source | Species | Neural markers assessed | ref. | |
|---|---|---|---|---|---|
| Carbon nanotube | Multiwall | Bone marrow | Human | GFAP, MAP2, NFL, NFM, NFH, β-III tubulin, Nestin,Synaptophysin | [ |
| Single-wall | Bone marrow | Human | Nestin, GFAP, MAP2, Tuj1 | [ | |
| Multiwall | Bone marrow | Human | β-III tubulin, NSE, GAP43, NFL, MAP1b, MAP2 | [ | |
| Multiwall | Bone marrow | Human | NF-L, GFAP | [ | |
| Carbon nanotube composite | Poly-lactic acid with alginate-gelatin and multiwall carbon nanotube coating | Wharton jelly | Human | Nestin, MAP2, NSE | [ |
| Single-wall carbon nanotube-pyrimethamine | Adipose | Human | NSE, NFM | [ | |
| Multiwall carbon nanotube-sericin | Bone marrow | Mouse | Tuj1 | [ | |
| Poly (lactic- | Adipose | Rat | Nestin, SOX II, βIII-tubulin, Synaptophysin | [ | |
Electroactive scaffolds for enhancing neurogenic differentiation of mesenchymal stem/stromal cells
| Electroactive scaffold material | Mesenchymal stem/stromal cell source | Species | Neural markers assessed | ref. |
|---|---|---|---|---|
| Poly (3,4-ethylenedioxythiophene) (PEDOT)-reduced graphene oxide (rGO) hybrid microfiber (80 μm in diameter) | Bone marrow | Rat | Tuj1, GFAP | [ |
| CoFe2O4 (CFO)-polyvinylidene difluoride (PVDF) nanocomposite | Adipose tissue | Human | Nestin, βIII-tubulin, NSE, β-Sarcomeric actin | [ |
| Agarose–alginate–chitosan–oligoaniline composite hydrogel | Olfactory mucosa | Human | MAP2, TH, DAT, Nurr1, Wnt1, Pitx3 | [ |
| Polyvinylidene difluoride (PVDF)-BaTiO3-multi-walled carbon nanotube (MWNT) nanocomposite | Bone marrow | Human | Nestin, βIII-tubulin, GFAP, MAP2 | [ |
Graphene-based electroconductive scaffolds for enhancing neurogenic differentiation of mesenchymal stem/stromal cells
| Electroconductive scaffold material | Mesenchymal stem/stromal cell source | Species | Neural markers assessed | ref. | |
|---|---|---|---|---|---|
| Graphene monolayer | Adipose | Human | Nestin, Tuj1, NeuN, GFAP | [ | |
| Graphene monolayer | Bone marrow | Human | Nestin, Tuj1, NF-L | [ | |
| Fluorinated graphene | Bone marrow | Human | Nestin, MAP2 Tuj1, | [ | |
| Graphene oxide | Adipose | Human | Tuj1 | [ | |
| Graphene oxide | Adipose | Human | BDNF, GDNF, NGF | [ | |
| Graphene and natural polymer composite scaffolds | Collagen-coated graphene foam | Bone marrow | Mouse | β-III tubulin, TH, NeuN | [ |
| Reduced graphene oxide – porcine acellular dermal matrix | Bone marrow | Rat | Nestin, GFAP, MAP2 | [ | |
| Graphene and synthetic polymer composite scaffolds | Electrospun polycaprolactone-graphene nanocomposite | Bone marrow | Human | β-III tubulin, TH, MAP-2 | [ |
| Graphene- polycaprolactone -gelatin nanofiber | Bone marrow | Rat | O4, O1, MOG | [ | |
| Graphene -polylactide- | Bone marrow | Human | Nestin, GFAP, TUJ1, MAP2 | [ | |
| Polyethylenimine (PEI) grafted graphene oxide | Bone marrow | Rat | β-III tubulin | [ | |
| Graphene oxide–poly (acrylic acid) nanocomposite hydrogel | Bone marrow | Rat | GFAP | [ | |
| Graphene-augmented ceramic composite scaffold | Graphene-augmented inorganic metal oxide ceramic | Adipose | Human | Nestin, GFAP, Tuj1 | [ |